How a drug development plan can save your biotech money
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of…
In association with Accelerating Clinical Trials
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of…
According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion by 2024 (+8% CAGR 19-24F).…
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates. The South…
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the global COVID-19 crisis. According to…
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
The alliance of regional specialists can provide the best of all worlds: global coverage, regional specialisation and mid-sized CRO flexibility.…
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…